DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vinblastine (Vinblastine) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Vinblastine and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (8)
Death (3)
Disability (2)

Reports by Reaction Type

Pancytopenia (4)Streptococcal Bacteraemia (3)Renal Failure Acute (3)Vomiting (3)Nausea (3)Carbon Monoxide Diffusing Capacity Decreased (3)Febrile Neutropenia (3)Coordination Abnormal (2)Peripheral Sensorimotor Neuropathy (2)Hypoaesthesia (2)Paraesthesia (2)Gait Disturbance (2)

Possible Vinblastine side effects in 29 year old female

Reported by a physician from Hungary on 2012-08-27

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Carboplatin
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Cisplatin
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Cytarabine
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Dacarbazine
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Dexamethasone Sodium Phosphate
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Doxorubicin HCL
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Doxorubicin HCL
    Dosage: unk
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Etoposide
    Dosage: unk
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Gemcitabine Hydrochloride
    Dosage: unk
    Indication: Hodgkin's Disease
    Start date: 2007-01-01

Ifosfamide
    Dosage: unk
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Ifosfamide
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Rituximab
    Dosage: unk
    Indication: Hodgkin's Disease
    Start date: 2007-01-01

Vinblastine
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Vinorelbine
    Dosage: unk
    Indication: Hodgkin's Disease
    Start date: 2007-01-01



Possible Vinblastine side effects in 28 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-11

Patient: 28 year old female

Reactions: Streptococcal Bacteraemia, Vomiting, Nausea, Peripheral Sensorimotor Neuropathy, Carbon Monoxide Diffusing Capacity Decreased, Pancytopenia, Febrile Neutropenia, Hypoaesthesia, Paraesthesia, Gait Disturbance, Coordination Abnormal, Renal Failure Acute

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: 15 units/m2 over 24h on day2

Cisplatin
    Dosage: 45 mg/m2, unk

Cisplatin
    Dosage: 90 mg/m2, over 4h on day1
    Indication: Ovarian Cancer

Cyclophosphamide
    Dosage: 750 mg/m2, unk

Cyclophosphamide
    Dosage: 1000 mg/m2, over 60min on day 2
    Indication: Ovarian Cancer

Doxorubicin HCL
    Dosage: 30 mg/m2, unk

Doxorubicin HCL
    Dosage: 45 mg/m2, over 30min on day3
    Indication: Ovarian Cancer

Etoposide
    Dosage: 200 mg/m2, over 2h on day3
    Indication: Ovarian Cancer

Etoposide
    Dosage: 100 mg/m2, unk

Vinblastine
    Dosage: 6 mg/m2, over 30 minutes on day 1
    Indication: Ovarian Cancer

Other drugs received by patient: Pegfilgrastim



Possible Vinblastine side effects in 28 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29

Patient: 28 year old female

Reactions: Streptococcal Bacteraemia, Vomiting, Nausea, Peripheral Sensorimotor Neuropathy, Carbon Monoxide Diffusing Capacity Decreased, Pancytopenia, Febrile Neutropenia, Hypoaesthesia, Paraesthesia, Coordination Abnormal, Gait Disturbance, Renal Failure Acute

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Bleomycin
    Dosage: 15 units/m2 over 24h on day2

Cisplatin
    Dosage: 90 mg/m2 over 4h on day1
    Indication: Ovarian Cancer

Cisplatin
    Dosage: 45 mg/m 2

Cyclophosphamide
    Dosage: 1000 mg/m2 over 60min on day 2
    Indication: Ovarian Cancer

Cyclophosphamide
    Dosage: 750 mg/m 2

Doxorubicin HCL
    Dosage: 45 mg/m2 over 30min on day3
    Indication: Ovarian Cancer

Doxorubicin HCL
    Dosage: 30 mg/m 2

Etoposide
    Dosage: 200 mg/m2 over 2h on day3
    Indication: Ovarian Cancer

Etoposide
    Dosage: 100 mg/m 2

Vinblastine
    Dosage: 6mg/m2 over 30min on day1
    Indication: Ovarian Cancer

Other drugs received by patient: Pegfilgrastim



Possible Vinblastine side effects in 28 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-04

Patient: 28 year old female

Reactions: Streptococcal Bacteraemia, Vomiting, Nausea, Carbon Monoxide Diffusing Capacity Decreased, Febrile Neutropenia, Pancytopenia, Neuropathy Peripheral, Bacteraemia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bleomycin Sulfate

Bleomycin Sulfate

Bleomycin Sulfate
    Indication: Ovarian Cancer

Bleomycin Sulfate

Cisplatin
    Indication: Ovarian Cancer

Cisplatin

Cisplatin

Cisplatin

Cisplatin

Cisplatin

Cyclophosphamide
    Indication: Ovarian Cancer

Cyclophosphamide

Cyclophosphamide

Cyclophosphamide

Cyclophosphamide

Cyclophosphamide

Doxorubicin HCL
    Dosage: cycle 5
    Indication: Ovarian Cancer

Doxorubicin HCL
    Dosage: cycle 3

Doxorubicin HCL
    Dosage: cycle 6

Doxorubicin HCL
    Dosage: cycle 1

Doxorubicin HCL
    Dosage: cycle 2

Doxorubicin HCL
    Dosage: cycle 4

Etoposide

Etoposide
    Indication: Ovarian Cancer

Etoposide

Etoposide

Etoposide

Etoposide

Vinblastine
    Indication: Ovarian Cancer

Vinblastine Sulfate

Vinblastine Sulfate

Vinblastine Sulfate

Vinblastine Sulfate

Vinblastine Sulfate

Other drugs received by patient: Pegfilgrastim; Pegfilgrastim; Pegfilgrastim; Pegfilgrastim; Pegfilgrastim; Pegfilgrastim



Possible Vinblastine side effects in

Reported by a physician from Italy on 2012-05-04

Patient:

Reactions: Death, Hodgkin's Disease Recurrent, Lung Disorder, Pulmonary Embolism, Treatment Failure, Lymphoma, Hodgkin's Disease

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Indication: Hodgkin's Disease

Doxorubicin HCL

Epirubicin Hydrochloride
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease

Lomustine
    Indication: Hodgkin's Disease

Mechlorethamine
    Indication: Hodgkin's Disease

Prednisone TAB
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Indication: Hodgkin's Disease

Vinblastine
    Indication: Hodgkin's Disease

Vincristine Sulfate
    Indication: Hodgkin's Disease

Vindesine
    Indication: Hodgkin's Disease



Possible Vinblastine side effects in 24 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-04

Patient: 24 year old female

Reactions: Mucosal Inflammation, Cellulitis, Pancytopenia

Drug(s) suspected as cause:
Bleomycin Sulfate

Bleomycin Sulfate

Bleomycin Sulfate

Bleomycin Sulfate

Bleomycin Sulfate
    Indication: Ovarian Cancer

Bleomycin Sulfate

Cisplatin

Cisplatin

Cisplatin

Cisplatin

Cisplatin
    Indication: Ovarian Cancer

Cisplatin

Cyclophosphamide
    Indication: Ovarian Cancer

Cyclophosphamide

Cyclophosphamide

Cyclophosphamide

Cyclophosphamide

Cyclophosphamide

Doxorubicin HCL
    Dosage: cycle 4

Doxorubicin HCL
    Dosage: cycle 6

Doxorubicin HCL
    Dosage: cycle 3

Doxorubicin HCL
    Dosage: cycle 2

Doxorubicin HCL
    Dosage: cycle 1
    Indication: Ovarian Cancer

Doxorubicin HCL
    Dosage: cycle 5

Etoposide

Etoposide

Etoposide

Etoposide

Etoposide
    Indication: Ovarian Cancer

Etoposide

Vinblastine

Vinblastine

Vinblastine

Vinblastine

Vinblastine
    Indication: Ovarian Cancer

Vinblastine

Other drugs received by patient: Pegfilgrastim; Pegfilgrastim; Pegfilgrastim; Pegfilgrastim; Pegfilgrastim; Pegfilgrastim



Possible Vinblastine side effects in 50 year old male

Reported by a physician from Greece on 2012-05-02

Patient: 50 year old male

Reactions: Multi-Organ Failure, Toxicity To Various Agents

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease

Ifosfamide
    Indication: Hodgkin's Disease

Mesna
    Indication: Hodgkin's Disease

Mitoxantrone Hydrochloride

Vinblastine
    Indication: Hodgkin's Disease



Possible Vinblastine side effects in

Reported by a physician from United States on 2012-02-08

Patient:

Reactions: Syndactyly, Maternal Exposure Timing Unspecified

Drug(s) suspected as cause:
Adriamycin PFS

Bleomycin

Dacarbazine

Vinblastine

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017